US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
Agency: Centers for Disease Control and Prevention - ERA
- 93.185 -- Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations.
Eligibility
Eligible applicants
Government
- Federally recognized Native American tribal governments
- County governments
- State governments
- City or township governments
- Public and Indian housing authorities
- Special district governments
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Miscellaneous
- Other
Education
- Public and state institutions of higher education
- Independent school districts
Additional information
Grantor contact information
Description
Grants Policy
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-IP-21-002.pdf | RFA-IP-21-002 | Jan 12, 2021 12:48 PM UTC |
| RFA-IP-21-002_Amend_1_03_03_21_.pdf | RFA-IP-21-002 Amend 1 | Mar 3, 2021 06:56 PM UTC |
Link to additional information
--
Archived: March 10, 2021
Award
$68,250,000
Program Funding
7
Expected awards
$1,600,000
Award Minimum
$1,950,000
Award Maximum
Funding opportunity number:
RFA-IP-21-002
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
7
Posted date:
November 17, 2020
Archive date:
March 10, 2021
